dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:35:05Z
dc.date.accessioned2022-10-05T13:45:01Z
dc.date.available2014-05-20T13:35:05Z
dc.date.available2022-10-05T13:45:01Z
dc.date.created2014-05-20T13:35:05Z
dc.date.issued1999-09-01
dc.identifierGynecologic Oncology. San Diego: Academic Press Inc., v. 74, n. 3, p. 375-380, 1999.
dc.identifier0090-8258
dc.identifierhttp://hdl.handle.net/11449/12047
dc.identifier10.1006/gyno.1999.5483
dc.identifierWOS:000082708100009
dc.identifier8814823545159504
dc.identifier0514178654667684
dc.identifier2259986546265579
dc.identifier0000-0002-0285-1162
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3887943
dc.description.abstractGenomic imprinting is defined as a gamete of origin-specific epigenetic modification of DNA leading to differential gene expression in the zygote. Several imprinted genes have been identified and some of them are associated with tumor development. We investigated the expression and the imprinting status of IGF2 and H19 genes in 47 uterine leiomyomas. Using allelic transcription assay, we detected the expression of the IGF2 gene in 10 of a total of 15 informative cases. No loss of imprinting, as determined by the finding of biallelic expression, was detected in any case. The expression of H19 gene was detected in 10 of 20 informative cases and the imprinting pattern was also maintained in all of them. Our data suggest that alterations in IGF2 and H19 genes expression by loss of imprinting do not occur in uterine leiomyomas. (C) 1999 Academic Press.
dc.languageeng
dc.publisherAcademic Press Inc.
dc.relationGynecologic Oncology
dc.relation4.540
dc.relation2,339
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectgenomic imprinting
dc.subjectgrowth factor
dc.subjectuterine tumors
dc.titleExpression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas
dc.typeArtigo


Este ítem pertenece a la siguiente institución